Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
NIH Grants & Funding for Thrombocytopenia Due to Immune Destruction | Kisho | Kisho
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Thrombocytopenia Due to Immune Destruction. Strongest funded area: Basic Science. Largest gap: Epidemiology / Natural History.
Biomarker / DiagnosticsPublished, Not NIH-Funded
17 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for thrombocytopenia due to immune destruction. Existing research activity suggests this may be a viable area for grant applications.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
78 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for thrombocytopenia due to immune destruction. Existing research activity suggests this may be a viable area for grant applications.
Clinical ResearchPublished, Not NIH-Funded
19 publications in Clinical Trial Publication but no NIH-funded grants found in Clinical Research for thrombocytopenia due to immune destruction. Existing research activity suggests this may be a viable area for grant applications.
Epidemiology / Natural HistoryPublished, Not NIH-Funded
45 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for thrombocytopenia due to immune destruction. Existing research activity suggests this may be a viable area for grant applications.
